Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial
Keyword(s):
Keyword(s):
2016 ◽
Vol 24
(12)
◽
pp. 4913-4920
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 16
(7)
◽
pp. 830-838
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 30
(3)
◽
pp. 333-344
◽
2020 ◽
Vol 43
(9)
◽
pp. 1285-1293
Keyword(s):
1987 ◽
Vol 5
(2)
◽
pp. 255-259
◽
Keyword(s):